The Polycyclo Ring System Is Attached Directly To A -c(=x)-nh- Group, Wherein X Is Chalcogen And Substitution May Be Made For Hydrogen Only, Which Group Is Between The Polycyclo Ring System And The 1-thia-4-aza Bicyclo(3.2.0)hep-tane Patents (Class 540/330)
  • Patent number: 9120783
    Abstract: The present invention relates to compounds of the formula I, wherein A, D, E, L, G, R10, R30, R40, R50 and R60 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cathepsin A, and are useful for the treatment of diseases such as atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases, for example. The invention furthermore relates to processes for the preparation of the compounds of the formula I, their use and pharmaceutical compositions comprising them.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: September 1, 2015
    Assignee: SANOFI
    Inventors: Sven Ruf, Thorsten Sadowski, Klaus Wirth, Herman Schreuder, Christian Buning
  • Patent number: 9068979
    Abstract: A micro bio sensor which detects a microbe existing in a specimen is provided. The microbial sensor includes a base, a detector formed on the base, and a reaction layer formed on the detector, wherein the reaction layer is comprised of a self-assembled monolayer which is formed on the detector and an antibiotic which is immobilized through the self-assembled monolayer on the detector. By using the micro bio sensor, it is possible to detect species of the microbe concurrently and improve sensitivity for detecting the species of the microbe. Further, a method for manufacturing such a micro bio sensor is also provided.
    Type: Grant
    Filed: May 20, 2008
    Date of Patent: June 30, 2015
    Assignee: Seiko Epson Corporation
    Inventors: Hitoshi Fukushima, Akira Nishimura, Mitsuhiro Ban, Asahi Yamazaki, Takuya Asai
  • Patent number: 7329652
    Abstract: The present invention relates to inhibitors of protein kinases, particularly to inhibitors of JAK2 and JAK3. The invention also provides pharmaceutical compositions comprising the compounds of the invention, processes for preparing the compounds and methods of using the compositions in the treatment of various disorders.
    Type: Grant
    Filed: September 19, 2005
    Date of Patent: February 12, 2008
    Assignee: Vertex Pharamaceuticals Incorporated
    Inventors: Francesco Salituro, Mark Ledeboer, Brian Ledford, Jian Wang, Albert Pierce, John Duffy, David Messersmith
  • Patent number: 5026716
    Abstract: A method of treatment of anxiety and depression in mammals is described which comprises administering to a mammal in need thereof an effective amount of a trifluoromethylphenyl-tetrahydropyridine derivative of formula I ##STR1## wherein Alk represents a straight or branched (C.sub.1 -C.sub.4)alkylene chain and R is selected from the group consisting of cyano, acetyl, (C.sub.3 -C.sub.7)cycloalkyl, pyridyl, 1-oxide-pyridyl and naphthyl, or of a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 17, 1989
    Date of Patent: June 25, 1991
    Assignee: Sanofi
    Inventors: Alberto Bianchetti, Gerard Le Fur, Jacques Simiand, Philippe Soubrie
  • Patent number: 4767851
    Abstract: An improved process is disclosed for the preparation of 7-amino and 7-substituted amino-desacetoxycephalosporins in which the corresponding 6-substituted amino penicillin sulphoxide is heated in the presence of an acidic substance which causes expansion of the penam ring in the reactant to the .DELTA..sup.3 cephem ring in the product in the presence of a silicon containing compound. The process comprises adding sulphamide or a silylsulphamide or a silylsulphamoyl to the reaction or utilizing a silylsulphamide or silylsulphamoyl as the silicon containing compound.
    Type: Grant
    Filed: July 8, 1985
    Date of Patent: August 30, 1988
    Assignee: Gema, S.A.
    Inventor: Alberto Palomo-Coll
  • Patent number: 4711956
    Abstract: The invention relates to penicillin derivatives of Formula I, and a method of synthesis; the derivatives having high antimicrobial activity against gram-positive and gram-negative microorganisms. ##STR1## R is selected from the group consisting of ##STR2## R.sub.1 is selected from the group consisting of hydrogen and a hydroxyl group;R.sub.2 is selected from the group consisting of hydrogen, an alkaline metal, and a carboxy protective group;R.sub.3 is selected from the group consisting of hydrogen, a lower alkyl, and a phenyl residue;R.sub.4, R.sub.5, and R.sub.6 are each selected from the group consisting of hydrogen, a halogen, a lower alkyd, and a lower alkoxy group;A is selected from the group consisting of oxygen and a N-(lower alkyl) residue; andn is 0 or 1.
    Type: Grant
    Filed: July 17, 1985
    Date of Patent: December 8, 1987
    Assignee: TPO "Pharmachim"
    Inventors: Ivanka A. Atanassova, Marieta A. Haimova, Vesselina B Chavdarova, Anton I. Nakov, Nedelcho G. Petkov, Ruska S. Avramova